Monlunabant
Monlunabant ((S) -MRI-1891) is a solid dispersion formulation of a selective cannabinoid CB1 receptor antagonist. It is utilized in preclinical research to investigate CB1 receptor function in metabolic, neurological, and psychiatric disorders, with applications in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
2712480-46-9
Field of Research
Pharmacology & Drug Discovery
Purity
99.95% (May vary between batches)
Smiles
C (NS (=O) (=O) C1=CC=C (C (F) (F) F) C=C1) (=NC (NC (C) =O) =N) N2N=C ([C@H] (C2) C3=CC=CC=C3) C4=CC=C (Cl) C=C4
Molecular Formula
C26H22ClF3N6O3S
Molecular Weight
591
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Wyb1341-1mgEcoli 1 mg (E. coli)
Recombinant Salmonella yraN Protein (aa 1-131)
Sign In for Pricing
View Details 
LV625166 1.0 µg DNA
SMCP Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details 